Celecoxib for the treatment of non muscle invasive bladder cancer. Results from the first phase II clinical trial

被引：1
|
作者：
Pagliarulo, V. [1 ]
Martines, I. [1 ]
Telari, S. [1 ]
Ancona, P. [1 ]
Trerotoli, P. [2 ]
Albo, G. [1 ]
Pagliarulo, A. [1 ]
机构：
[1] Univ Bari, Sezione Urol, DETO, I-70121 Bari, Italy
[2] Univ Bari, Dipartimento Med Interna & Med Publ, I-70121 Bari, Italy
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2008年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1569-9056(08)60909-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
912
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [41] Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT)
    Goossens M.
    Zeegers M.
    Van Poppel H.
    Joniau S.
    Ackaert K.
    Ameye F.
    Billiet I.
    Dillen K.
    Goeman L.
    Van Bruwaene S.
    Van der Aa F.
    Vekemans K.
    Buntinx F.
    Archives of Public Health, 73 (Suppl 1)
  • [42] RESULTS OF CALIBER: A PHASE II RANDOMISED FEASIBILITY TRIAL OF CHEMOABLATION VERSUS SURGICAL MANAGEMENT IN LOW RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Mostafid, Hugh
    Cresswell, Joanne
    Griffiths, Leyshon
    Kelly, John
    Knight, Allen
    Catto, James
    Davenport, Kim
    Feber, Andrew
    Knowles, Margaret
    McGrath, John
    Cooke, Peter
    Masood, Shikohe
    Goubar, Aicha
    Penegar, Steven
    Porta, Nuria
    Wiley, Laura
    Lewis, Rebecca
    Hall, Emma
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1231 - E1231
  • [43] Realizing the potential of targeted therapy in non-muscle invasive bladder cancer.
    Black, Peter C.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 22 - 22
  • [44] Intravesical treatment of non-muscle-invasive bladder cancer
    Bahlburg, Henning
    Noldus, Joachim
    Roghmann, Florian
    UROLOGIE, 2025,
  • [45] Diagnosis and treatment of non-muscle-invasive bladder cancer
    Mostafid, Hugh
    Bryan, Richard T.
    Rees, Jonathan
    TRENDS IN UROLOGY & MENS HEALTH, 2015, 6 (02) : 23 - +
  • [46] A phase II trial of risk-adapted treatment for muscle invasive bladder cancer after neoadjuvant accelerated MVAC.
    Geynisman, Daniel M.
    Abbosh, Philip
    Zibelman, Matthew R.
    Feldman, Rebecca
    McConkey, David James
    Hahn, Noah M.
    Bivalacqua, Trinity
    Trabulsi, Edouard John
    Lallas, Costas D.
    Hoffman-Censits, Jean H.
    Viterbo, Rosalia
    Horwitz, Eric M.
    Churilla, Thomas M.
    Alpaugh, R. Katherine
    Greenberg, Richard E.
    Smaldone, Marc C.
    Uzzo, Robert
    Chen, David
    Kutikov, Alexander
    Plimack, Elizabeth R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [47] Study on the Treatment of non-muscle invasive Bladder Cancer
    Rexer, H.
    UROLOGE, 2015, 54 (03): : 406 - 408
  • [48] Fosciclopirox clinical proof of concept in patients with nonmuscle invasive and muscle-invasive bladder cancer.
    Weir, Scott James
    Kessler, Elizabeth R.
    Kukreja, Janet Baack
    Falchook, Gerald Steven
    Bupathi, Manojkumar
    Parikh, Rahul Atul
    Wulff-Burchfield, Elizabeth Marie
    Wood, Robyn
    Lee, Eugene K.
    Ham, Tammy
    Dandawate, Prasad
    Anant, Shrikant
    Woolbright, Benjamin L.
    Zhang, Na
    Toren, Paul
    Dalton, Michael
    Zhukova-Harrill, Valentina
    Umbreit, Jay Nicholas
    McCulloch, William
    Taylor, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16557 - E16557
  • [49] Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial
    Valérie Fonteyne
    Piet Dirix
    Sara Junius
    Elke Rammant
    Piet Ost
    Gert De Meerleer
    Martijn Swimberghe
    Karel Decaestecker
    BMC Cancer, 17
  • [50] Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial
    Fonteyne, Valerie
    Dirix, Piet
    Junius, Sara
    Rammant, Elke
    Ost, Piet
    De Meerleer, Gert
    Swimberghe, Martijn
    Decaestecker, Karel
    BMC CANCER, 2017, 17
12345